UAB CFRC Administrative Core
UAB CFRC Administrative Core
批准号:
10673354
负责人:
David M. Bedwell
金额:
$13.96万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
未结题
起止时间:
2007-04-01 至 2028-04-30
关键词:
AccelerationAdvisory CommitteesAreaBiochemistryBiomedical ResearchBreast Fibrocystic DiseaseBusinessesCOVID-19Career MobilityCellsClinical SciencesCollaborationsCommunicationCommunitiesCore FacilityCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorDevelopmentDiabetes MellitusDiseaseEnsureEnvironmentEquipmentEvaluationEvolutionFacultyFosteringFoundationsFundingGoalsGrantGrowthHuman ResourcesInstitutionInterdisciplinary StudyInvestmentsLeadershipMedicineMolecular GeneticsMonitorMusNational Institute of Diabetes and Digestive and Kidney DiseasesNewsletterObesityParticipantPediatricsPositioning AttributeProceduresProductivityProgram DevelopmentRattusRecommendationResearchResearch PersonnelResourcesScienceScientistSiteSite VisitSystemTechnologyTrainingTranslational ResearchTranslationsUnited States National Institutes of HealthUtilization ReviewWritingbasecareer developmentclinical centerdrug developmentequipment acquisitionexperiencegene therapygenetic technologyinnovationinnovative technologiesinventionmeetingsmembermucus clearancenext generationnovelnutritionoperationpandemic diseaseprogramsresearch and developmentskillssuccesssymposiumsynergismweb site
中文摘要
项目摘要/摘要
UAB囊性纤维化研究和翻译核心中心管理核心负责
全面管理和协调生物医学研究核心、试点和可行性计划,以及
浓缩计划。《行政核心》由Bedwell博士(P30主管)Birket和所罗门执导
(副主任),以及罗博士(副主任)的持续参与,此外
旨在确保与CF基金会的倡议建立无缝的合作伙伴关系。吉姆贝洛博士将担任
与伯克特博士共同担任浓缩项目主任。在这一领导下,在
经验丰富的研究管理和行政团队(包括中心的Jeffrey Allison先生
(行政主任和计划主任艾米丽·福尔克-利比博士),核心将继续
通过以下方式成功地支持CF中心在即将到来的资金周期中的目标:1)建立总体科学的
UAB P30 CF中心的方向,并确保继续贡献和增长到最相关的
疾病领域,包括基因疗法的应用(例如,指导
行政核心、P30调查员、中心活跃的内部咨询委员会成员和/或
外部咨询委员会的外部顾问,以审查中心的活动并确定研究方向
和机会),2)促进所有P30组件的目标(例如,确定核心资源的优先顺序和
采购新设备以实现最佳利用,监督新的最先进的核心研究空间和
设施,协调培训和职业发展活动,维护中心网站,
监督成员资格,建设生物医学核心研究基地并监测其生产率,
支持内部和外部协作,管理新冠肺炎的成功运营),以及3)
将P30组件与其他UAB NIH中心整合(例如,促进和共享其创新资源
并与其他中心领导进行沟通,如临床和转化科学中心
(UAB的CTSA网站),NIDDK-糖尿病研究和培训中心,NIDDK-营养性肥胖研究
中心和NIDDK-肝肾纤维囊性疾病核心中心),以确定持续的机会
多学科协作。此外,还特别支持该中心的浓缩和试点工作。
可行性方案,行政核心将继续确定和整合通过以下途径提供的资源
该机构旨在最大限度地提高实习生的成功,并向初级教员过渡到独立以及申请
它建立了强大的P30试点申请征集、审查和监督机制,以促进新的
以及对CF科学的重要贡献。总体而言,行政核心的目标是优化
促进CFP30中心内部的协同和进步。
英文摘要
PROJECT SUMMARY/ABSTRACT
The UAB Cystic Fibrosis Research and Translation Core Center Administrative Core is responsible for the
overall administration and coordination of the Biomedical Research Cores, Pilot & Feasibility Program, and
Enrichment Program. The Administrative Core is directed by Drs. Bedwell (P30 Director) Birket, and Solomon
(Associate Directors), along with continued involvement from Dr. Rowe (Associate Director) that additionally
serves to assure a seamless partnership with initiatives from the CF Foundation. Dr. Guimbellot will serve as
Co-Director of the Enrichment Program with Dr. Birket. Under this leadership, with assistance from the
experienced Research Management and Administrative Team (including Mr. Jeffrey Allison, Center
Administrative Director, and Dr. Emily Falk-Libby, Program Director-Scientific Affairs), the Core will continue to
successfully support CF Center goals in the upcoming funding cycle by: 1) Establishing the overall scientific
direction of the UAB P30 CF Center and ensuring continued contributions and growth into the most relevant
disease areas, including application of genetic therapies (e.g., directing communications between the
Administrative Core, P30 investigators, members of the Center’s active Internal Advisory Board, and/or
external consultants on its External Advisory Board to review Center activities and identify research directions
and opportunities), 2) Facilitating the objectives of all P30 components (e.g., prioritizing Core resources and
new equipment acquisition for optimal utilization, overseeing new state-of-the-art Core research space and
facilities, coordinating training and professional development activities, maintaining a Center website,
overseeing membership, building the Biomedical Core research base and monitoring its productivity,
supporting internal and external collaborations, managing successful operations in COVID-19), and 3)
Integrating P30 components with other UAB NIH Centers (e.g., promoting and sharing its innovative resources
and communicating with other Center leadership such as the Center for Clinical and Translational Science
(UAB’s CTSA site), NIDDK-Diabetes Research and Training Center, NIDDK-Nutrition Obesity Research
Center, and NIDDK-Hepatorenal Fibrocystic Diseases Core Center) to identify continued opportunities for
multidisciplinary collaboration. In addition, specifically in support of the Center’s Enrichment and Pilot &
Feasibility Programs, the Administrative Core will continue to identify and integrate resources offered through
the Institution to maximize trainee success and transition to independence for junior faculty as well as to apply
its established, robust mechanisms for solicitation, review, and oversight of P30 pilot applications to foster new
and important contributions to CF science. Overall, it is the goal of the Administrative Core to optimally
promote synergy and progress within the CF P30 Center.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New Nonsense Suppression Drugs to Treat MPS I
-
批准号:8842247
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2014
-
负责人:David M. Bedwell
-
依托单位:
Mechanism of Eukaryotic Translation Termination
-
批准号:7997463
-
项目类别:
-
资助金额:$4.38万
-
财政年份:2009
-
负责人:David M. Bedwell
-
依托单位:
Suppression of the Idua-W402X mutation in an MPS I-H mouse
-
批准号:7340377
-
项目类别:
-
资助金额:$31.72万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Suppression of the Idua-W402X mutation in an MPS I-H mouse
-
批准号:7179609
-
项目类别:
-
资助金额:$31.72万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Suppression of the Idua-W402X mutation in an MPS I-H mouse
-
批准号:8015606
-
项目类别:
-
资助金额:$31.08万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Animal Models Core
-
批准号:8320678
-
项目类别:
-
资助金额:$32.52万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
UAB CF Research and Translation Core Center
-
批准号:10673353
-
项目类别:
-
资助金额:$111.38万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Suppression of the Idua-W402X mutation in an MPS I-H mouse
-
批准号:7560341
-
项目类别:
-
资助金额:$31.72万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
UAB CF Research and Translation Core Center
-
批准号:10468801
-
项目类别:
-
资助金额:$111.37万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Mouse Models Core
-
批准号:7288652
-
项目类别:
-
资助金额:$16.12万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Animal Models Core
-
批准号:8451289
-
项目类别:
-
资助金额:$31.28万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Core B - Animal and Preclinical Models Core
-
批准号:10246451
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Animal Models Core
-
批准号:8851578
-
项目类别:
-
资助金额:$32.52万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Core B - Animal and Preclinical Models Core
-
批准号:10468805
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Suppression of the Idua-W402X mutation in an MPS I-H mouse
-
批准号:7761315
-
项目类别:
-
资助金额:$31.4万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Mechanism of Eukaryotic Translation Termination
-
批准号:7067093
-
项目类别:
-
资助金额:$27.4万
-
财政年份:2003
-
负责人:David M. Bedwell
-
依托单位:
Mechanism of Eukaryotic Translation Termination
-
批准号:7371536
-
项目类别:
-
资助金额:$30.45万
-
财政年份:2003
-
负责人:David M. Bedwell
-
依托单位:
Mechanism of Eukaryotic Translation Termination
-
批准号:7534977
-
项目类别:
-
资助金额:$34.66万
-
财政年份:2003
-
负责人:David M. Bedwell
-
依托单位:
Mechanism of Eukaryotic Translation Termination
-
批准号:7995246
-
项目类别:
-
资助金额:$29.84万
-
财政年份:2003
-
负责人:David M. Bedwell
-
依托单位:
Mechanism of Eukaryotic Translation Termination
-
批准号:6897183
-
项目类别:
-
资助金额:$28.06万
-
财政年份:2003
-
负责人:David M. Bedwell
-
依托单位:
海外基金